AAAAAA

   
Results: 1-25 | 26-50 | 51-51
Results: 26-50/51
SMOKING AND TRAIT ANXIETY
Authors: CANALS J DOMENECH E BLADE J
Citation: J. Canals et al., SMOKING AND TRAIT ANXIETY, Psychological reports, 79(3), 1996, pp. 809-810
SPLENOMEGALIC PANCYTOPENIA OF PROBABLE IM MUNE ORIGIN - CURE AFTER TREATMENT WITH GLUCOCORTICOIDS
Authors: FUENTES A FELIU E BLADE J CAMPO E RIBERA JM CERVANTES F ROZMAN C
Citation: A. Fuentes et al., SPLENOMEGALIC PANCYTOPENIA OF PROBABLE IM MUNE ORIGIN - CURE AFTER TREATMENT WITH GLUCOCORTICOIDS, Medicina Clinica, 106(7), 1996, pp. 263-266
VERTEBRAL HEMANGIOMA AND SMOLDERING MYELO MA - ASSOCIATION WITH THERAPEUTIC SIGNIFICANCE
Authors: MARTINEZ C BLADE J BERENGUER J MERCADER JM ROZMAN C
Citation: C. Martinez et al., VERTEBRAL HEMANGIOMA AND SMOLDERING MYELO MA - ASSOCIATION WITH THERAPEUTIC SIGNIFICANCE, Medicina Clinica, 106(5), 1996, pp. 185-187
CYTOKINE THERAPY IN MULTIPLE-MYELOMA
Authors: PEEST D BLADE J HAROUSSEAU JL KLEIN B OSTERBORG A SANMIGUEL JF
Citation: D. Peest et al., CYTOKINE THERAPY IN MULTIPLE-MYELOMA, British Journal of Haematology, 94(3), 1996, pp. 425-432
PRESENTING FEATURES AND PROGNOSIS IN 72 PATIENTS WITH MULTIPLE-MYELOMA WHO WERE YOUNGER THAN 40 YEARS
Authors: BLADE J KYLE RA GREIPP PR
Citation: J. Blade et al., PRESENTING FEATURES AND PROGNOSIS IN 72 PATIENTS WITH MULTIPLE-MYELOMA WHO WERE YOUNGER THAN 40 YEARS, British Journal of Haematology, 93(2), 1996, pp. 345-351
ALLOGENEIC BONE-MARROW TRANSPLANTATION VERSUS AUTOLOGOUS STEM-CELL TRANSPLANTATION IN MULTIPLE-MYELOMA - A RETROSPECTIVE CASE-MATCHED STUDYFROM THE EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATION
Authors: BJORKSTRAND B LJUNGMAN P SVENSSON H HERMANS J ALEGRE A APPERLEY J BLADE J CARLSON K CAVO M FERRANT A GOLDSTONE AH DELAURENZI A MAJOLINO I MARCUS R PRENTICE HG REMES K SAMSON D SUREDA A VERDONCK LF VOLIN L GAHRTON G
Citation: B. Bjorkstrand et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION VERSUS AUTOLOGOUS STEM-CELL TRANSPLANTATION IN MULTIPLE-MYELOMA - A RETROSPECTIVE CASE-MATCHED STUDYFROM THE EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATION, Blood, 88(12), 1996, pp. 4711-4718
VCMP VBAP AT STANDARD DOSES (SD) VS VCMP/VBAP AT HIGHER DOSES (HD) OFCYCLOPHOSPHAMIDE AND DOXORUBICIN AS INITIAL TREATMENT OF MULTIPLE-MYELOMA (MM)/
Authors: BLADE J SANMIGUEL JF ESCUDERO ML MALDONADO J BRUNET S GARDELLA S ALCALA A CARNERO M CARBONELL F GARCIACONDE J BESALDUCH J MARTI JM RIBERA JM ATUCHA J FERNANDEZCALVO J FONT L MORO MJ FONTANILLAS M ESTAPE J MONTSERRAT E
Citation: J. Blade et al., VCMP VBAP AT STANDARD DOSES (SD) VS VCMP/VBAP AT HIGHER DOSES (HD) OFCYCLOPHOSPHAMIDE AND DOXORUBICIN AS INITIAL TREATMENT OF MULTIPLE-MYELOMA (MM)/, Blood, 88(10), 1996, pp. 2336-2336
MULTIPLE-MYELOMA IN PATIENTS YOUNGER THAN 30 YEARS - REPORT OF 10 CASES AND REVIEW OF THE LITERATURE
Authors: BLADE J KYLE RA GREIPP PR
Citation: J. Blade et al., MULTIPLE-MYELOMA IN PATIENTS YOUNGER THAN 30 YEARS - REPORT OF 10 CASES AND REVIEW OF THE LITERATURE, Archives of internal medicine, 156(13), 1996, pp. 1463-1468
TREATMENT OF MULTIPLE-MYELOMA IN ELDERLY PEOPLE - LONG-TERM RESULTS IN 178 PATIENTS
Authors: BLADE J MUNOZ M FONTANILLAS M SANMIGUEL J ALCALA A MALDONADO J BESSES C MORO MJ GARCIACONDE J ROZMAN C MONTSERRAT E ESTAPE J
Citation: J. Blade et al., TREATMENT OF MULTIPLE-MYELOMA IN ELDERLY PEOPLE - LONG-TERM RESULTS IN 178 PATIENTS, Age and ageing, 25(5), 1996, pp. 357-361
AN UPDATE OF PROGNOSTIC FACTORS FOR ALLOGENEIC BONE-MARROW TRANSPLANTATION IN MULTIPLE-MYELOMA USING MATCHED SIBLING DONORS
Authors: GAHRTON G TURA S LJUNGMAN P BLADE J CAVO M DELAURENZI A FACON T GRATWOHL A MICHALLET M NIKOSKELAINEN J PEARCE R REIFFERS J SAMSON D SCHATTENBERG A VERDONCK L VERNANT JP VOLIN L
Citation: G. Gahrton et al., AN UPDATE OF PROGNOSTIC FACTORS FOR ALLOGENEIC BONE-MARROW TRANSPLANTATION IN MULTIPLE-MYELOMA USING MATCHED SIBLING DONORS, Stem cells, 13, 1995, pp. 122-125
AUTOLOGOUS STEM-CELL TRANSPLANTATION IN MULTIPLE-MYELOMA - RESULTS OFTHE EUROPEAN GROUP FOR BONE-MARROW TRANSPLANTATION
Authors: BJORKSTRAND B LJUNGMAN P BIRD JM SAMSON D BRANDT L ALEGRE A AUZANNEAU G BLADE J BRUNET S CARLSON K CAVO M FERRANT A GRAVETT P DELAURENZI A PRENTICE HG PROCTOR S REMES K TROUSSARD X VERDONCK LF WILLIAMS C GAHRTON G
Citation: B. Bjorkstrand et al., AUTOLOGOUS STEM-CELL TRANSPLANTATION IN MULTIPLE-MYELOMA - RESULTS OFTHE EUROPEAN GROUP FOR BONE-MARROW TRANSPLANTATION, Stem cells, 13, 1995, pp. 140-146
MULTIPLE-MYELOMA FOLLOWING ESSENTIAL THROMBOCYTHEMIA
Authors: COBO F CERVANTES F MARTINEZ C SALGADO C BLADE J MONTSERRAT E ROZMAN C
Citation: F. Cobo et al., MULTIPLE-MYELOMA FOLLOWING ESSENTIAL THROMBOCYTHEMIA, Leukemia & lymphoma, 20(1-2), 1995, pp. 177
ALTERNATING VCMP VBAP AT STANDARD DOSES (SD) VS VCMP/VBAP AT INTERMEDIATE DOSES (ID) AS INITIAL TREATMENT OF MULTIPLE-MYELOMA (MM)/
Authors: BLADE J SANMIGUEL JF ESCUDERO ML FONTANILLAS M
Citation: J. Blade et al., ALTERNATING VCMP VBAP AT STANDARD DOSES (SD) VS VCMP/VBAP AT INTERMEDIATE DOSES (ID) AS INITIAL TREATMENT OF MULTIPLE-MYELOMA (MM)/, European journal of cancer, 31A, 1995, pp. 774-774
PATIENTS WITH MULTIPLE-MYELOMA (MM) REQUIRING LONG-TERM HEMODIALYSIS (HD) - PRESENTING FEATURES, RESPONSE TO THERAPY AND SURVIVAL IN A SERIES OF 20 PATIENTS
Authors: BLADE J TORRA R CASES A LOPEZPEDRET J MONTSERRAT E REVERT L ROZMAN C
Citation: J. Blade et al., PATIENTS WITH MULTIPLE-MYELOMA (MM) REQUIRING LONG-TERM HEMODIALYSIS (HD) - PRESENTING FEATURES, RESPONSE TO THERAPY AND SURVIVAL IN A SERIES OF 20 PATIENTS, European journal of cancer, 31A, 1995, pp. 778-778
PROGNOSTIC FACTORS IN ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR MULTIPLE-MYELOMA
Authors: GAHRTON G TURA S LJUNGMAN P BLADE J BRANDT L CAVO M FACON T GRATWOHL A HAGENBEEK A JACOBS P DELAURENZI A VANLINT M MICHALLET M NIKOSKELAINEN J REIFFERS J SAMSON D VERDONCK L DEWITTE T VOLIN L
Citation: G. Gahrton et al., PROGNOSTIC FACTORS IN ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR MULTIPLE-MYELOMA, Journal of clinical oncology, 13(6), 1995, pp. 1312-1322
ALLOGENEIC BONE-MARROW TRANSPLANTATION IN MULTIPLE-MYELOMA - ANALYSISOF 12 CONSECUTIVE CASES
Authors: BLADE J CARRERAS E ROZMAN C SIERRA J ROVIRA M BATLLE M VALLS A ALGARA M MARIN P URBANOISPIZUA A MERINO A BESSON I MONTSERRAT E
Citation: J. Blade et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION IN MULTIPLE-MYELOMA - ANALYSISOF 12 CONSECUTIVE CASES, Medicina Clinica, 105(1), 1995, pp. 1-4
PATIENTS WITH MULTIPLE-MYELOMA REQUIRING LONG-TERM DIALYSIS - PRESENTING FEATURES, RESPONSE TO THERAPY, AND OUTCOME IN A SERIES OF 20 CASES
Authors: TORRA R BLADE J CASES A LOPEZPEDRET J MONTSERRAT E ROZMAN C REVERT L
Citation: R. Torra et al., PATIENTS WITH MULTIPLE-MYELOMA REQUIRING LONG-TERM DIALYSIS - PRESENTING FEATURES, RESPONSE TO THERAPY, AND OUTCOME IN A SERIES OF 20 CASES, British Journal of Haematology, 91(4), 1995, pp. 854-859
SURVIVAL OF PATIENTS WITH MULTIPLE-MYELOMA WHO ARE POTENTIAL CANDIDATES FOR EARLY INTENSIFICATION WITH HIGH-DOSE THERAPY - LONG-TERM RESULTS WITH CONVENTIONAL CHEMOTHERAPY
Authors: BLADE J SANMIGUEL JF FONTANILLAS M
Citation: J. Blade et al., SURVIVAL OF PATIENTS WITH MULTIPLE-MYELOMA WHO ARE POTENTIAL CANDIDATES FOR EARLY INTENSIFICATION WITH HIGH-DOSE THERAPY - LONG-TERM RESULTS WITH CONVENTIONAL CHEMOTHERAPY, Blood, 86(10), 1995, pp. 1752-1752
LOW-GRADE LYMPHOMA - CLINICAL AND PROGNOSTIC STUDIES IN A SERIES OF 143 PATIENTS FROM A SINGLE INSTITUTION
Authors: LOPEZGUILLERMO A MONTSERRAT E BOSCH F ESCODA L TEROL MJ MARIN P REVERTER JC BLADE J CERVANTES F SIERRA J NOMDEDEU B URBANOISPIZUA A ROUIRA M CARRERAS E CAMPO E ROZMAN C
Citation: A. Lopezguillermo et al., LOW-GRADE LYMPHOMA - CLINICAL AND PROGNOSTIC STUDIES IN A SERIES OF 143 PATIENTS FROM A SINGLE INSTITUTION, Leukemia & lymphoma, 15(1-2), 1994, pp. 159-165
IMMUNOGLOBULIN-D MULTIPLE-MYELOMA - PRESENTING FEATURES, RESPONSE TO THERAPY, AND SURVIVAL IN A SERIES OF 53 CASES
Authors: BLADE J LUST JA KYLE RA
Citation: J. Blade et al., IMMUNOGLOBULIN-D MULTIPLE-MYELOMA - PRESENTING FEATURES, RESPONSE TO THERAPY, AND SURVIVAL IN A SERIES OF 53 CASES, Journal of clinical oncology, 12(11), 1994, pp. 2398-2404
SEPSIS BY CANDIDA-TROPICALIS IN PATIENTS WITH GRANULOCYTOPENIA - A STUDY OF 10 CASES
Authors: TEROL MJ TASSIES D LOPEZGUILLERMO A MARTINORTEGA E BLADE J CERVANTES F GARCIA C MONTSERRAT E ROZMAN C
Citation: Mj. Terol et al., SEPSIS BY CANDIDA-TROPICALIS IN PATIENTS WITH GRANULOCYTOPENIA - A STUDY OF 10 CASES, Medicina Clinica, 103(15), 1994, pp. 579-582
IGD MONOCLONAL GAMMOPATHY WITH LONG-TERM FOLLOW-UP
Authors: BLADE J KYLE RA
Citation: J. Blade et Ra. Kyle, IGD MONOCLONAL GAMMOPATHY WITH LONG-TERM FOLLOW-UP, British Journal of Haematology, 88(2), 1994, pp. 395-396
IMPACT OF RESPONSE TO TREATMENT ON SURVIVAL IN MULTIPLE-MYELOMA - RESULTS IN A SERIES OF 243 PATIENTS
Authors: BLADE J LOPEZGUILLERMO A BOSCH F CERVANTES F REVERTER JC MONTSERRAT E ROZMAN C
Citation: J. Blade et al., IMPACT OF RESPONSE TO TREATMENT ON SURVIVAL IN MULTIPLE-MYELOMA - RESULTS IN A SERIES OF 243 PATIENTS, British Journal of Haematology, 88(1), 1994, pp. 117-121
LARGE-CELL LYMPHOMA - A STUDY OF PROGNOSTIC FACTORS AND ASSESSMENT OF5 RECENTLY PROPOSED PREDICTIVE SYSTEMS
Authors: LOPEZGUILLERMO A MONTSERRAT E REVERTER JC CERVANTES F ESCODA L TASSIES D BLADE J MARIN P SIERRA J ORDI J ROZMAN C
Citation: A. Lopezguillermo et al., LARGE-CELL LYMPHOMA - A STUDY OF PROGNOSTIC FACTORS AND ASSESSMENT OF5 RECENTLY PROPOSED PREDICTIVE SYSTEMS, Leukemia & lymphoma, 10(1-2), 1993, pp. 101-109
ALTERNATING COMBINATION VCMP VBAP CHEMOTHERAPY VERSUS MELPHALAN PREDNISONE IN THE TREATMENT OF MULTIPLE-MYELOMA - A RANDOMIZED MULTICENTRICSTUDY OF 487 PATIENTS
Authors: BLADE J SANMIGUEL JF ALCALA A MALDONADO J SANZ MA GARCIACONDE J MORO MJ ALONSO C BESALDUCH J ZUBIZARRETA A BESSES C GONZALEZBRITO G HERNANDEZMARTIN J FERNANDEZCALVO J RUBIO D ORTEGA F JIMENEZ R COLOMINAS P FAURA MV FONT L TORTOSA J DOMINGO A FONTANILLAS M ROZMAN C ESTAPE J
Citation: J. Blade et al., ALTERNATING COMBINATION VCMP VBAP CHEMOTHERAPY VERSUS MELPHALAN PREDNISONE IN THE TREATMENT OF MULTIPLE-MYELOMA - A RANDOMIZED MULTICENTRICSTUDY OF 487 PATIENTS, Journal of clinical oncology, 11(6), 1993, pp. 1165-1171
Risultati: 1-25 | 26-50 | 51-51